Back to search

Netherlands· NL-4e0bd4633167

Fluticasonpropionaat Xiromed 0,5 mg/g crème

A fluticasone product containing fluticasonpropionaat, registered in Netherlands by Medical Valley Invest AB. The same ATC class is registered in 10 of our 19 countries.

ATC D07AC17

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedFluticasonpropionaat Xiromed 0,5 mg/g…ATCD07AC17REGISTER NO.NL-4e0bd4633167PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Fluticasone is registered in 10 of 19 countries.

Countries holding a registration under ATC D07AC17 (fluticasone), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 7 of them publish a price we can compare per daily dose

Fluticasone · ATC D07AC17

10 / 19 countries

  • Belgiumprice
  • Finlandprice
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
FLUTICASONPROPIONAAT
Manufacturer
Medical Valley Invest AB
Country
Netherlands (NL)
ATC code
D07AC17
ATC class
Fluticasone
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    117523

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

56 interactions on record for fluticasone.

Graded by severity as the source publishes them — 1 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Fluticasone · interactions on record

56 records

  • 1 moderate
  • 55 minor

Most severe, free to view

  • EchinaceaD03AH02moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Fluticasone in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All fluticasone products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Flixonase Aquosum, Flixotide Diskus Forte
  • Belgium · Flixonase Aqua, Flixotide
  • Bulgaria · Аркуист, Фликсоназе
  • Cyprus · Cutivate, Flixonase Aqueous
  • Czechia · Flixotide Diskus, Flixotide Inhaler N
  • Germany · Flutica, Fluticason Cipla
  • Denmark · Flixotide, Flurhin
  • Estonia · Cutivate Cream, Flixonase
  • Spain · Avancort, Flixonase
  • Finland · Flixonase, Flixotide Diskus
  • France · Fixorinox, Flixonase
  • United Kingdom (Northern Ireland) · Aeronate, Boots Allergy Relief
  • Greece · Alerxem, Bocacort-S
  • Croatia · Flixonase, Flixotide Inhaler
  • Hungary · Cutivate, Flixonase
  • Ireland · Arquist, Flixonase Allergy Relief
  • Iceland · Avamys, Flixotide
  • Italy · Aktanos, Deflut
  • Liechtenstein · Avamys
  • Lithuania · Cutivate, Flixotide
  • Luxembourg · Flixonase Aqua, Flixotide
  • Latvia · Flixonase, Flixotide
  • Malta · Cutivate, Flihaler
  • Norway · Avamys, Flurhin
  • Poland · Cutivate, Fanipos
  • Portugal · Brisovent Diskus, Brisovent Inalador
  • Romania · Arquist, Cutivate
  • Sweden · Arquist, Fluticasone Cipla
  • Slovenia · Flixonase, Flixotide
  • Slovakia · Flixonase Aqueous, Flixotide Diskus

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d7a8a97f-8c0b-4a4f-9f4b-9953277c76fe
GET /v1/drugs/d7a8a97f-8c0b-4a4f-9f4b-9953277c76fe?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Crème",
  "route": "Cutaan gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h117523_smpc.pdf",
  "strength": null,
  "atc_label": "Fluticasone",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg117523",
  "excipients": [
    "CETOSTEARYLALCOHOL",
    "CITROENZUUR 0-WATER (E 330)",
    "DINATRIUMWATERSTOFFOSFAAT 0-WATER (E 339)",
    "IMIDUREUM",
    "ISOPROPYLMYRISTAAT",
    "MACROGOLCETOSTEARYLETHER",
    "PARAFFINE, VLOEIBAAR (E905)",
    "PROPYLEENGLYCOL (E 1520)",
    "WATER, GEZUIVERD"
  ],
  "substances": [
    "FLUTICASONPROPIONAAT"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h117523.pdf",
  "authorised_at": "2019/01/21",
  "procedure_number": "NL/H/3524/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "117523",
  "additional_monitoring": "N"
}

See everything about fluticasone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.